AUPH CIK: 1600620

Aurinia Pharmaceuticals Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
44.5
FY22:
128
FY23:
161
FY24:
207
FY25:
250
(positive)
Change from FY21 to FY25
millions USD
FY21:
−181
FY22:
−111
FY23:
−106
FY24:
−32.9
FY25:
72.2
(positive)
Change from FY21 to FY23
millions USD
FY21:
−177
FY22:
−104
FY23:
−63.0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−180
FY22:
−106
FY23:
−77.5
FY24:
7.45
FY25:
114
(positive)
Change from FY21 to FY25
millions USD
FY21:
−181
FY22:
−108
FY23:
−78.0
FY24:
5.75
FY25:
287

All amounts in millions USD Data sources:SEC EDGARTwelve Data